The ASMQ - FDC.

• From: Department for International Development
• Published: 1 January 2009

• Document Type: Conference Paper
• Theme: Health
• Authors: Kiechel, J.R.

Abstract

This presentation describes the new fixed-dose antimalarial formulation ASMQ (artesunate + mefloquine) and its advantages in terms of ease of use, efficacy and tolerability (as well as contraindications); reasons why it needs further study in Africa are given.

Citation

Presentation from ‘The ASMQ Fixed-Dose Combination to treat Malaria: From Blueprint to Use in the Field’. Symposium from American Society of Tropical Medicine and Hygiene 58th Annual Meeting, Washington, DC, USA, 19 November 2009.

Links

The ASMQ - FDC.

Published 1 January 2009